CellaVision
245
SEK
+1,45 %
CEVI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
1.502 investorer følger denne virksomhed
ir.cellavision.com
CellaVision is active in medical technology. The company's operations develop and market image analysis systems for diagnosing blood and other body fluids. The products are intended to replace traditional microscope analysis. Operations are conducted on a global level, primarily in the Nordic countries, Europe and North America, where customers consist of research institutes. The head office is located in Lund.
Omsætning
677,29 mio.
EBIT %
24,66 %
P/E
44,87
Udbytteafkast, %
0,92 %
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
CEVI
Daglig lav / høj pris
239 / 248,5
SEK
Markedsværdi
5,84 mia. SEK
Aktieomsætning
2,25 mio. SEK
Volumen
9,3 t
Seneste videoer
Finanskalender
Årsrapport
06.02.2025
Delårsrapport
29.04.2025
Generalforsamling
06.05.2025
Delårsrapport
18.07.2025
Delårsrapport
06.11.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
William Demant Invest | 19,9 % | 19,9 % |
Grenlunden CEVI AB | 10,0 % | 10,0 % |
SEB Fonder | 9,2 % | 9,2 % |
Christer Fåhraeus o bol | 6,8 % | 6,8 % |
Swedbank Robur fonder | 5,4 % | 5,4 % |
Invesco | 3,8 % | 3,8 % |
Fjärde AP-fonden | 3,0 % | 3,0 % |
Handelsbanken Fonder | 2,9 % | 2,9 % |
La Financière de l'Echiquier | 2,6 % | 2,6 % |
AMF Pension & Fonder | 2,5 % | 2,5 % |
ViserAlle indholdstyper
Redeye: Cellavision Q3’2024 - Underlying momentum intact
CellaVision, Audiocast with teleconference, Q3'24
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools